A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Eisai Inc.
BeiGene
City of Hope Medical Center
Columbia University
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
National Institutes of Health Clinical Center (CC)
University of Nebraska
University of Nebraska
Columbia University
Stanford University
Atara Biotherapeutics
Karyopharm Therapeutics Inc
Ludwig Institute for Cancer Research
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Soligenix
Alexion Pharmaceuticals, Inc.
Rochester Skin Lymphoma Medical Group, PLLC
Novartis
Roswell Park Cancer Institute
Eisai Inc.
Roswell Park Cancer Institute
Galderma R&D
Takeda
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Eli Lilly and Company
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Mayo Clinic
Helsinn Therapeutics (U.S.), Inc
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Rhizen Pharmaceuticals SA
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Bausch Health Americas, Inc.
Celgene
Roswell Park Cancer Institute
Mayo Clinic
Mayo Clinic
Abramson Cancer Center at Penn Medicine
University of Chicago
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center